Compare Eli Lilly And Co (LLY) vs Valero Energy Corporation (VLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Valero Energy Corporation — how do they compare? Eli Lilly And Co trades at $1,179.27 (market cap $1.04T), while Valero Energy Corporation trades at $433.75 (market cap $127.78B). The key difference: Eli Lilly And Co is far larger — about 8.1× Valero Energy Corporation's market cap, and Valero Energy Corporation pays the higher dividend (1.08%). Which is the better fit depends on your goals — on Pluang, investors hold Eli Lilly And Co for 93 Days and Valero Energy Corporation for 56 Days on average.
| LLY | VLO | |
|---|---|---|
Market Cap | $1.04T | $127.78B |
Volume | 3,064,878 | 2,570,225 |
Sector | Health | Energy |
52-Week High | $1.28K | $443.80 |
52-Week Low | $799.57 | $156.39 |
Typical Hold Time | 93 Days | 56 Days |
Enterprise Value | $1.09T | $131.26B |
Dividend Yield | 0.59% | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,169.93, down 1.58% on the day, but maintains strong bullish momentum with consistent earnings beats and robust revenue growth. The company demonstrates exceptional profitability with 83.4% gross margins and 33.53% net income margins, supported by dominant positioning in weight-loss and diabetes treatments. Recent clinical trial successes for next-generation drugs and expanded FDA approvals reinforce growth prospects.
LLY presents compelling growth potential with analyst consensus target of $1,350 representing 15% upside, though elevated valuations (P/E 39.26) and increasing competition in obesity drugs pose risks. Strong institutional support (73% buy ratings) and positive pipeline developments support continued momentum, but investors should monitor execution risks and market saturation concerns.
Valero Energy (VLO) trades at $443.8, up 4.65% today, near its 52-week high. The stock shows strong technical momentum with bullish moving averages, though RSI levels indicate overbought conditions. Fundamentally, VLO has beaten earnings estimates for three consecutive quarters, with Q3 2026 expected at $20.17 EPS. Revenue has declined from $176.4B in 2022 to $122.7B in 2025, but net income margin improved to 5.17% in 2026 projections. Analyst sentiment is predominantly positive with 54% buy ratings.
VLO's outlook is supported by refining margin strength and a solid balance sheet, but risks include potential diesel export bans and volatile energy markets. The consensus price target is $408.10, below the current price, suggesting limited near-term upside. Investors should weigh strong operational performance against macroeconomic and policy uncertainties in the energy sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Valero Energy Corporation
Valero Energy is one of the largest independent refiners in the United States. It operates 14 refineries with a total throughput capacity of 3.2 million barrels a day in the United States, Canada, and the United Kingdom. Valero also owns 14 ethanol plants with capacity of 1.7 billion gallons of ethanol a year and holds a 50% stake in Diamond Green Diesel, which has capacity to produce 700 million gallons per year of renewable diesel.
Read more on VLO →
